Accelerated re-epithelialization of partial-thickness skin wounds by a topical betulin gel: Results of a randomized phase III clinical trials program
- PMID: 28400148
- DOI: 10.1016/j.burns.2017.03.005
Accelerated re-epithelialization of partial-thickness skin wounds by a topical betulin gel: Results of a randomized phase III clinical trials program
Abstract
The clinical significance of timely re-epithelialization is obvious in burn care, since delayed wound closure is enhancing the risk of wound site infection and extensive scarring. Topical treatments that accelerate wound healing are urgently needed to reduce these sequelae. Evidence from preliminary studies suggests that betulin can accelerate the healing of different types of wounds, including second degree burns and split-thickness skin graft wounds. The goal of this combined study program consisting of two randomized phase III clinical trials in parallel is to evaluate whether a topical betulin gel (TBG) is accelerating re-epithelialization of split-thickness skin graft (STSG) donor site wounds compared to standard of care. Two parallel blindly evaluated, randomised, controlled, multicentre phase III clinical trials were performed in adults undergoing STSG surgery (EudraCT nos. 2012-003390-26 and 2012-000777-23). Donor site wounds were split into two equal halves and randomized 1:1 to standard of care (a non-adhesive moist wound dressing) or standard of care plus TBG consisting of 10% birch bark extract and 90% sunflower oil (Episalvan, Birken AG, Niefern-Oeschelbronn, Germany). The primary efficacy assessment was the intra-individual difference in time to wound closure assessed from digital photographs by three blinded experts. A total of 219 patients were included and treated in the two trials. Wounds closed faster with TBG than without it (15.3 vs. 16.5 days; mean intra-individual difference=-1.1 days [95% CI, -1.5 to -0.7]; p<0.0001). This agreed with unblinded direct clinical assessment (difference=-2.1 days [95% CI, -2.7 to -1.5]; p<0.0001). Adverse events possibly related to treatment were mild or moderate and mostly at the application site. TBG accelerates re-epithelialization of partial thickness wounds compared to the current standard of care, providing a well-tolerated contribution to burn care in practice.
Keywords: Intra-individual comparison; Split thickness skin graft; Topical betulin gel; Wound closure; Wound healing.
Copyright © 2017 The Authors. Published by Elsevier Ltd.. All rights reserved.
Similar articles
-
Betulin wound gel accelerated healing of superficial partial thickness burns: Results of a randomized, intra-individually controlled, phase III trial with 12-months follow-up.Burns. 2019 Jun;45(4):876-890. doi: 10.1016/j.burns.2018.10.019. Epub 2018 Dec 14. Burns. 2019. PMID: 30559054 Clinical Trial.
-
Accelerating the aesthetic benefit of wound healing by triterpene.J Craniomaxillofac Surg. 2012 Jul;40(5):e150-4. doi: 10.1016/j.jcms.2011.07.020. Epub 2011 Aug 26. J Craniomaxillofac Surg. 2012. PMID: 21872485 Clinical Trial.
-
Split-thickness skin grafting: early outcomes of a clinical trial using different graft thickness.J Wound Care. 2018 Jan 2;27(1):5-13. doi: 10.12968/jowc.2018.27.1.5. J Wound Care. 2018. PMID: 29333934 Clinical Trial.
-
Topical Aloe Vera Gel for Accelerated Wound Healing of Split-Thickness Skin Graft Donor Sites: A Double-Blind, Randomized, Controlled Trial and Systematic Review.Plast Reconstr Surg. 2018 Jul;142(1):217-226. doi: 10.1097/PRS.0000000000004515. Plast Reconstr Surg. 2018. PMID: 29649056 Clinical Trial.
-
The Wound Healing Properties of Betulin from Birch Bark from Bench to Bedside.Planta Med. 2019 May;85(7):524-527. doi: 10.1055/a-0850-0224. Epub 2019 Mar 11. Planta Med. 2019. PMID: 30856673 Review.
Cited by
-
Leading edge: emerging drug, cell, and gene therapies for junctional epidermolysis bullosa.Expert Opin Biol Ther. 2020 Aug;20(8):911-923. doi: 10.1080/14712598.2020.1740678. Epub 2020 Mar 20. Expert Opin Biol Ther. 2020. PMID: 32178539 Free PMC article. Review.
-
Interventions for postburn pruritus.Cochrane Database Syst Rev. 2024 Jun 5;6(6):CD013468. doi: 10.1002/14651858.CD013468.pub2. Cochrane Database Syst Rev. 2024. PMID: 38837237 Free PMC article.
-
Betulin-3,28-diphosphate. Physico-Chemical Properties and In Vitro Biological Activity Experiments.Molecules. 2018 May 14;23(5):1175. doi: 10.3390/molecules23051175. Molecules. 2018. PMID: 29757999 Free PMC article.
-
A Retrospective Self-Controlled Study Evaluating the Prophylactic Effects of CACIPLIQ20 on Postsurgical Scars.Aesthet Surg J Open Forum. 2023 Mar 23;5:ojad031. doi: 10.1093/asjof/ojad031. eCollection 2023. Aesthet Surg J Open Forum. 2023. PMID: 37051418 Free PMC article.
-
Insights into the mechanisms of diabetic wounds: pathophysiology, molecular targets, and treatment strategies through conventional and alternative therapies.Inflammopharmacology. 2024 Feb;32(1):149-228. doi: 10.1007/s10787-023-01407-6. Epub 2024 Jan 11. Inflammopharmacology. 2024. PMID: 38212535 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous